Timing of first-line cancer treatments - Early versus late - A systematic review of phase III randomized trials

Cancer Treatment Reviews

Volumn 36, Issue 8, 2010, Pages 621-628

  Mhaskar, A R ^a   Quinn, G ^a   Vadaparampil, S ^a   Djulbegovic, B ^a   Gwede, C K ^a   Kumar, A ^a  

^a NONE   (United States)

Author keywords

Early late; Meta analysis; Treatment timing

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FOLLICULAR LYMPHOMA; HORMONAL THERAPY; HUMAN; LUNG CANCER; META ANALYSIS; MULTIPLE MYELOMA; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE III AS TOPIC; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LUNG NEOPLASMS; MALE; MULTIPLE MYELOMA; NEOPLASMS; PROGNOSIS; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 78349306957     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2010.04.001     Document Type: Review

References (35)

1. Quinn G.P., Vadaparampil S.T., Lee J., Jacobsen P.B., Bepler G., Lancaster J., et al. Physician referral for fertility preservation with oncology patients: a national study of practice behaviors. J Clin Oncol 2009, 27(35):5952-5957.
2. Zapzalka D.M., Redmon J.B., Pryor J.L. A survey of oncologists regarding sperm cryopreservation and assisted reproductive techniques for male cancer patients. Cancer 1999, 86(9):1812-1817.
3. Studer U.E., Whelan P., Albrecht W., Casselman J., de Reijke T., Hauri D., et al. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European organisation for research and treatment of cancer (EORTC) trial 30891. J Clin Oncol 2006, 24(12):1868-1876.
4. The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the medical research council trial. The medical research council prostate cancer working party investigators group. Br J Urol 1997;79(2):235-46.
5. Graefen M., Walz J., Chun K.H., Schlomm T., Haese A., Huland H. Reasonable delay of surgical treatment in men with localized prostate cancer-impact on prognosis?. Eur Urol 2005, 47(6):756-760.
6. Hjorth M., Hellquist L., Holmberg E., Magnusson B., Rodjer S., Westin J., et al. Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I - a randomized study. Eur J Haematol 1993, 50(2):95-102.
7. Riccardi A., Mora O., Tinelli C., Valentini D., Brugnatelli S., Spanedda R., et al. Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Br J Cancer 2000, 82(7):1254-1260.
8. Riccardi A., Ucci G., Luoni R., Brugnatelli S., Mora O., Spanedda R., et al. Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cytostatic policy. Br J Cancer 1994, 70(6):1203-1210.
9. Knobf M.T. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. Oncologist 2006, 11(2):96-110.
10. Schover L.R. Motivation for parenthood after cancer: a review. J Natl Cancer Inst 2005, 34:2-5.
11. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR, for the Hedges T. Optimal search strategies for retrieving scientifically strong studies of treatment from medline: analytical survey. BMJ 2005;330(7501):1179.
12. Work E., Nielsen O.S., Bentzen S.M., Fode K., Palshof T. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. J Clin Oncol 1997, 15(9):3030-3037. Aarhus Lung Cancer Group.
13. Altman D.G., Schulz K.F., Moher D., Egger M., Davidoff F., Elbourne D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001, 134(8):663-694.
14. Juni P., Altman D.G., Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323(7303):42-46.
15. Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008.
16. Egger M, Smith GD, Altman, DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ; 2001.
17. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
18. Parmar M.K., Torri V., Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17(24):2815-2834.
19. Parmar M.K.B., Torri V., Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17:2815-2834.
20. Egger M., Smith D.G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
21. Review Manager (Revman) [computer program]. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration; 2008 [version 5.0].
22. StataCorp. Stata statistical software, release 10. College Station, TX: StataCorp LP; 2007.
23. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
24. The French Cooperative Group on Chronic Lymphocytic Leukemia. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients. Blood 1990;75(7):1414-21.
25. Brice P., Bastion Y., Lepage E., Brousse N., Haioun C., Moreau P., et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. J Clin Oncol 1997, 15(3):1110-1117.
26. Brugiatelli M., Jaksic B., Planinc-Peraica A., Kusec R., Ostojic S., Callea V., et al. Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: long-term results of a randomized trial. Eur J Haematol 1995, 55(3):158-163.
27. Falk S.J., Girling D.J., White R.J., Hopwood P., Harvey A., Qian W., et al. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. BMJ 2002, 325(7362):465.
28. Lundgren R., Nordle O., Josefsson K. Immediate estrogen or estramustine phosphate therapy versus deferred endocrine treatment in nonmetastatic prostate cancer: a randomized multicenter study with 15 years of followup. J Urol 1995, 153(5):1580-1586. The South Sweden Prostate Cancer Study Group.
29. Montori V.M., Permanyer-Miralda G., Ferreira-Gonzalez I., Busse J.W., Pacheco-Huergo V., Bryant D., et al. Validity of composite end points in clinical trials. BMJ 2005, 330(7491):594-596.
30. Vidal L., Gafter-Gvili A., Leibovici L., Dreyling M., Ghielmini M., Hsu Schmitz S.F., et al. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst 2009, 101(4):248-255.
31. CLL Trialists' Collaborative Group. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. J Natl Cancer Inst 1999;91(10):861-8.
32. He Y, Wheatley K, Clark O, Glasmacher A, Ross H, Djulbegovic B. Early versus deferred treatment for early stage multiple myeloma. Cochrane Database Syst Rev 2003;(1):CD004023.
33. Quinn G.P., Vadaparampil S.T., Gwede C.K., Miree C., King L.M., Clayton H.B., et al. Discussion of fertility preservation with newly diagnosed patients: oncologists' views. J Cancer Surviv 2007, 1(2):146-155.
34. Vadaparampil S., Quinn G., King L., Wilson C., Nieder M. Barriers to fertility preservation among pediatric oncologists. Patient Educ Couns 2008, 72(3):402-410.
35. Lee S.J., Schover L.R., Partridge A.H., Patrizio P., Wallace W.H., Hagerty K., et al. American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006, 24(18):2917-2931.